The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 18, 1990

Filed:

Jul. 06, 1987
Applicant:
Inventors:

Michael J Bjorn, Hercules, CA (US);

David J FitzGerald, Fairfax, VA (US);

Arthur E Frankel, Durham, NC (US);

Walter J Laird, Pinole, CA (US);

Ira H Pastan, Potomac, MD (US);

David B Ring, Redwood City, CA (US);

Mark C Willingham, Bethesda, MD (US);

Jeffrey L Windelhake, Alameda, CA (US);

Assignee:

Cetus Corporation, Emeryville, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K / ; A61K / ;
U.S. Cl.
CPC ...
530389 ; 530388 ; 530387 ; 530390 ; 530391 ; 530808 ; 424 8591 ; 514885 ;
Abstract

Immunotoxins comprising a cytotoxic moiety and monoclonal antibodies which bind to human ovarian cancer tissue having at least one of the following capabilities are claimed: cytotoxic ID.sub.50 of 10 nM or less against human ovarian cancer cells, retardation of human ovarian cancer tumor growth in mammals or extension of survival of a mammal carrying a human ovarian cancer tumor. Antigens to which the monoclonal antibody of the immunotoxin bind are identified and characterize the immunotoxins. Methods of killing human ovarian cancer cells, retarding the growth of human ovarian cancer tumors in mammals or extending the survival of mammals carrying human ovarian cancer tumors are claimed.


Find Patent Forward Citations

Loading…